SII qHPV vaccine against cervical cancer to be launched by year-end, to be priced between Rs 200-400: Adar Poonawalla Ruchika Sharma1 Sept 2022 4:20 PM IST"The vaccine would be much much less in price as compared to other vaccines for cervical cancer," Poonawalla said.
Serum institute CEO expects Omicron-specific vaccine in 6 months: Report Ruchika Sharma17 Aug 2022 11:00 AM ISTNew Delhi: Serum Institute of India's (SII) Chief Executive Officer Adar Poonawalla said he expects an Omicron-specific vaccine in the country in six...
Serum Institute conducting research to find vaccine against monkeypox: Adar Poonawalla Ruchika Sharma3 Aug 2022 5:08 PM ISTMonkeypox typically manifests itself with fever, rash and swollen lymph nodes and may lead to a range of medical complications. It is usually a...
Vaccine maker SII to set up first manufacturing plant in Africa Ruchika Sharma25 May 2022 11:15 AM ISTAsked about possible investments, Poonawalla said such projects typically required at least around $300 million.
Serum Institute CEO warns against return to business-as-usual approach Ruchika Sharma23 April 2022 10:30 AM IST"The momentum of the past that brought us so far here is lost. As you said it seems for them, it's business as usual," Poonawalla said.
Serum institute Covovax first Indian COVID vaccine to be sold in Europe: Adar Poonawalla Ruchika Sharma13 April 2022 11:52 AM ISTCalling it an "important milestone, the CEO said, "We hope that in future other vaccines made in India will also be accepted and used in Europe.
Serum Institute Covishield Booster Shot to cost Rs 600 Per Shot Roshni Dhar11 April 2022 10:41 AM ISTVaccine maker Serum Institute of India (SII) on Friday said the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600...
Serum Institute Covishield booster shot to be available at Rs 600 per shot for individuals above 18 years Ruchika Sharma9 April 2022 12:12 PM IST"End-users will pay Rs 600 for the booster dose and the hospitals will get at a discounted price," Poonawalla said in a statement.
PharmEasy parent API Holdings and 2 others get SEBI go-ahead to float IPOs MD Bureau25 Feb 2022 12:51 PM ISTNew Delhi: API Holdings, the parent company of pharmacy platform PharmEasy, Adar Poonawalla-backed Wellness Forever Medicare and metal recycling firm...
Serum Institute chief picks up 20 percent stake in Wakau Ruchika Sharma23 Dec 2021 12:19 PM ISTNew Delhi: Serum Institute of India (SII) Chief Adar Poonawaalla has picked up a 20 per cent stake in Wakau Interactive, a short-video sharing...
Vaccine hesitancy big threat for India: SII Ruchika Sharma19 Nov 2021 5:26 PM ISTNew Delhi: Indian states are sitting on more than 200 million doses of COVID-19 vaccines due to a reluctance among people to get inoculated, the chief...
Serum Institute sees 'large' Covid-19 vaccine exports as output nearly quadruples Ruchika Sharma22 Oct 2021 12:46 PM ISTNew Delhi: The Serum Institute of India (SII), the world's biggest vaccine maker, has nearly quadrupled its monthly capacity of AstraZeneca shots...
